Jeffrey Henke
Surgery · Dallas, TXNPI 1811194384
Payments from drug & device makers
Across 76 payments — averaging $134.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Endo Pharmaceuticals Inc.$319
- Johnson & Johnson$266
- AbbVie$118
- Stryker$117
- Novo Nordisk$77
- plus $379 from 13 others
What the payments were for
- Travel & lodging$1,04010%
- Food & beverage$2,16821%
- Education$7,00069%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $8,933 |
| Endo Pharmaceuticals Inc. | 18 | $319 |
| Johnson & Johnson(2 entities) | 8 | $266 |
| AbbVie | 6 | $118 |
| Stryker | 4 | $117 |
| Novo Nordisk | 4 | $77 |
| Conmed Corporation | 1 | $50 |
| Davol Inc. | 2 | $47 |
| KCI USA, Inc. | 1 | $41 |
| Eisai Inc. | 2 | $33 |
| Heron Therapeutics, Inc. | 2 | $33 |
| Acacia Pharma Inc | 1 | $31 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Cook Medical LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Covidien LP | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,588
- Enseal X1 5mm$109
How this compares
$10,208 in reported general payments places this provider in the 70th percentile of 1,830 surgery providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 33 | $36,537 |
| Pantoprazole Sodium | 32 | $374 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $77 | $36,53733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,830 surgery providers in Texas.
Other surgery in Dallas
- Sachin KukrejaDallas$645K
- Malcolm MacconmaraDallas$635K
- Walton TaylorDallas$369K
- Steven LeedsDallas$217K
- Aaron HoffmanDallas$210K
- Lam leDallas$180K
- Benjamin LeviDallas$145K
- Funda MericHouston$20.6M
- Michael HarkinsTomball$2.7M
- Lloyd StegemannCorpus Christi$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.